- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer - Abstract
September 21, 2012
Review of hypofractionated radiotherapy for prostate cancer - Abstract
September 21, 2012
Sequencing of cabazitaxel in metastatic castrate-resistant prostate cancer: A case report - Abstract
September 21, 2012
A comparison of virtual touch tissue quantification and digital rectal examination for discrimination between prostate cancer and benign prostatic hyperplasia - Abstract
September 21, 2012
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: Efficacy and safety of denosumab - Abstract
September 21, 2012
Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer: Matched-pair analysis - Abstract
September 21, 2012
HPV persistence and its oncogenic role in prostate tumors - Abstract
September 21, 2012
Prostate cancer in African American men: Making awareness a priority, a community-based effort
September 20, 2012
Charlie Wilson brings the message home: “Don’t be afraid to talk about prostate cancer.”
September 20, 2012
Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner - Abstract
September 20, 2012
MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: Initial feasibility in humans - Abstract
September 20, 2012
Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer - Abstract
September 20, 2012
Factors associated with satisfaction with prostate cancer care: Results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) - Abstract
September 20, 2012
Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-Year outcomes - Abstract
September 20, 2012
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer - Abstract
September 20, 2012
Associations between intake of folate, methionine, and vitamins B-12, B-6 and prostate cancer risk in American veterans - Abstract
September 20, 2012